Login

4D Pharma hopes to expand drug success to other areas - Duncan Peyton, CEO, 4D Pharma 00:00:00

Share On Facebook Share On Twitter

4D Pharma hopes to expand drug success to other areas

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
The Right Value and the Right Clients with Guest Jason Speciner | JASON SPECINER - DIRECTOR OF INVESTMENT AND TAX PLANNING, FOUNDER
00:10:00
Insights into Banking Stress and Fed Policy with Jim Jackson of Victory Capital | Jackson, CIO , Victory Capital .
00:10:00
Insights into Credit Trends and Federal Reserve Influence| James Zelter, Co-president, Apollo Global Management.
00:10:00
Architect Your Business Like A Product doesn’t mean anything|Douglas Leone,founder,Sequoia
00:10:00
Introducing Blue Trust | Bethany Frymire, Financial Advisor at Blue Trust
00:10:00
Deciding When and How to Sell Your Business with Mentor Securities
00:10:00
Key Fund Management Insights from Michael Reeves
00:10:00
Benoist Grossmann Discusses IDInvest's Venture Capital Strategy and Early Career Influences | Benoist Grossmann, Managing Partner, Idinvest Partners.
00:10:00
Innovating Sustainability: Insights from Berry Global's John Vassallo and Jessica Wojnicki Rodriguez at CPHI Milan | John Vassallo - VP Global R&D, Jessica Wojnicki Rodriguez - Sustainability Project Manager, Berry Global
00:10:00
Yellowcake PLC CEO Andre Liebenberg Discusses Company Strategy and Uranium Market
00:10:00
ADT CEO Jim DeVries Talks Growth, Google Partnership, and Tech Future | Jim DeVries - Chairman of adt inc
00:10:00
Oliver Davies Discusses Sky Metals' Growth and Prospects in the Tin Market at the ASX Conference

© 2017 - Neuhu+